Added to YB: 2025-09-09
Pitch date: 2025-07-23
DGX [bullish]
Quest Diagnostics Incorporated
+5.8%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally.
Market Cap
$20.5B
Pitch Price
$172.53
Price Target
230.00 (+25%)
Dividend
1.74%
Sector
Health Care Providers and Services
Category
growth
Show full summary:
Quest Diagnostics Incorporated - $DGX
DGX: Duopoly w/ LabCorp in clinical testing serving 50% hospitals, 33% US adults. Trades cheap despite recurring revenue from chronic disease tailwinds & early detection trends. 2026 est: $11.2B revenue, $2.3B EBITDA, $1.2B FCF. EPS $10.50+ by 2026, $11.50+ 2027. 20x P/E = $230 target. Catalysts: unhealthier population driving test demand.
Read full article (4 min)